Clearside Biomedical, Inc.
CLSDDelisted Dec 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001539029
Clearside Biomedical, Inc. was delisted on Dec 8, 2025; its insiders filed their last Form 4 on Feb 24, 2025; 26 institutions reported holding it in 13F filings for Q3 2025, worth $2.18M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Clearside Biomedical, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 60 | 1 | 53 | −6 |
| Shares | 16.4M | 31.3K | 13.7M | −2.63M (−16.1%) |
| Value | $37.5M | $72.0K | $20.1M | −$17.3M (−46.2%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held Clearside Biomedical, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Acadian Asset Management LLC | 35,333 | $51.0K | 0.00% |
| ExodusPoint Capital Management, LP | 12,780 | $19.0K | 0.00% |
| Merit Financial Group, LLC | 11,000 | $16.0K | 0.00% |
| Investors Asset Management of Georgia Inc | 250 | $0 | 0.00% |
Sold out (10)
Institutions that held Clearside Biomedical, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Jane Street Group, LLC | 86,216 | $197.0K |
| XTX Topco Ltd | 50,947 | $117.0K |
| Principal Financial Group Inc | 45,373 | $104.0K |
| Newman Dignan & Sheerar, Inc. | 27,023 | $62.0K |
| Bailard, Inc. | 25,600 | $59.0K |
| Two Sigma Securities, LLC | 21,652 | $50.0K |
| Cubist Systematic Strategies, LLC | 19,200 | $44.0K |
| Bayesian Capital Management, LP | 15,500 | $35.0K |
| C M Bidwell & Associates Ltd | 1,165 | $3.00K |
| Royal Bank of Canada | 380 | $1.00K |
Not filed for Q2 2022 yet (1)
Institutions that held Clearside Biomedical, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Golden State Equity Partners | 31,327 | $72.0K |